# Clustering Approach 3 : CN_CNMF
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	4.81246644931099e-05	Range of duration = 0.03 to 187.07, nDeath = 40, nCensor = 374
2	AGE	ANOVA	3.1405632099238e-09	Range of values = 31 to 90, Mean = 63.4484, StdDev = 11.1508, nMissing = 1
3	HISTOLOGICAL.TYPE	Chi-square test	1.39488932177818e-32	nTypes = 7 (ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA/ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2)/ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1)/ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2)/ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3)/MIXED SEROUS AND ENDOMETRIOID/SEROUS ENDOMETRIAL ADENOCARCINOMA), nPatients = 308/3/8/2/7/16/74
4	RADIATIONS.RADIATION.REGIMENINDICATION	Chi-square test	0.106949838566794	nTypes = 2 (NO/YES), nPatients = 129/289
5	NEOADJUVANT.THERAPY	Chi-square test	0.0103497230488046	nTypes = 2 (NO/YES), nPatients = 102/316
